Current Vascular Pharmacology
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 3
Author(s): Aurelio Leone
Affiliation:
Export Options
About this article
Cite this article as:
Leone Aurelio , Meet Our Editorial Board Member, Current Vascular Pharmacology 2018; 16 (3) . https://dx.doi.org/10.2174/157016111603180326112112
DOI https://dx.doi.org/10.2174/157016111603180326112112 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
20
1
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chronic Kidney Disease and Cardiovascular Disease: A Focus on Primary Care
Cardiovascular & Hematological Disorders-Drug Targets Cutting through the Complexities of mTOR for the Treatment of Stroke
Current Neurovascular Research Impact of Pre-procedural Cerebrovascular Events on Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis
Current Pharmaceutical Design Current Algorithms for the Diagnosis of wide QRS Complex Tachycardias
Current Cardiology Reviews Chemistry and Pharmacology of Bioactive Molecule -Coenzyme Q10: A Brief Note
Current Bioactive Compounds Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues
Endocrine, Metabolic & Immune Disorders - Drug Targets Transient Receptor Potential Vanilloid 1 and Xenobiotics
CNS & Neurological Disorders - Drug Targets Is Bilirubin a Marker of Vascular Disease and/or Cancer and is it a Potential Therapeutic Target?
Current Pharmaceutical Design A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 2: Pharmacodynamic Modeling and Distribution on Ligand-Target Space of Effective Components
Letters in Drug Design & Discovery CASC15: A Tumor-Associated Long Non-Coding RNA
Current Pharmaceutical Design The Role of Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Drug Development for Ischemic Stroke: From Laboratory to Clinics
Current Vascular Pharmacology Pro-Drugs for Indirect Cannabinoids as Therapeutic Agents
Current Drug Delivery From the Editors Perspective: Activity, Anoxia, Angiogenesis, and Alzheimers Disease
Current Neurovascular Research The No-Reflow Phenomenon in the Coronary Circulation
Cardiovascular & Hematological Agents in Medicinal Chemistry Elucidations of Molecular Mechanism and Mechanistic Effects of Environmental Toxicants in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Insight γ-Secretase: Structure, Function, and Role in Alzheimer’s Disease
Current Drug Targets Synthesis and Pharmacological Profile of a Series of 1-substituted-2-Carbonyl Derivatives of Diphenidol: Novel M4 Muscarinic Receptor Antagonists
Medicinal Chemistry Role of the heme oxygenase-adiponectin-atrial natriuretic peptide axis in renal function
Current Pharmaceutical Design Future of Protease Activity Assays
Current Pharmaceutical Design Patent Selections
Recent Patents on Biomarkers